DEKA – A year of significant change

After 2016, a year in which we posted record results, 2017 is proving to be a year of transition and change.
A process of renewal has begun both internally and externally, explains El.En. General Manager
Paolo Salvadeo.
From an in-house point of view, a corporate reorganization has begun, looking to maximize co-ordination and create product synergies and economies of scale that, in turn, will lead to cost benefits and thus enable us to compete more effectively in the global market.

From an external point of view, our distribution network received a boost recently with an important new player joining our ranks: Hologic, an American colossus in the women’s health sector, who took over the distribution of MonaLisa Touch in the USA and Canada. Hologic has an almost 60-year history of making diagnostic, gynaecological and oncological surgical tools. An undisputed leader in the gynaecology sector, with a wealth of market knowledge. It goes without saying that this is a great opportunity for DEKA, one that will further boost the presence and help expand MonaLisa Touch across North America, where the vaginal rejuvenation market is showing very interesting growth prospects. Hologic CEO, Stephen P. MacMillan, says Hologic’s acquisition of Cynosure “will turbo charge sales for the DEKA MonaLisa Touch® in North America”.

Also from a marketing point of view, we have significant news. Responding to an increasing need for minimally invasive surgical solutions for localized fat and cellulite deposits, here at DEKA we are currently designing a highly innovative technology that will be launched on the European market by 2018. Experimentation and clinical trials are under way to
fine-tune the technology, but we are delighted to announce that the system will introduce effective improvements for patients, but also significant benefits for the physicians and practitioners who
will be using it.
DEKA has always been an innovation leader, and the goal we have set is to maintain and consolidate this through cross fertilization, R&D investment, better coordination and sounder awareness of market needs. A future full of new challenges and commitments awaits us, and we are coming up with the right tools to deal with them!

Paolo Salvadeo
El.En. Group General Manager

Recommended Posts